We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Mitochondrial Peptide Protects Brain from Age-Related Dementias

By LabMedica International staff writers
Posted on 04 Oct 2018
A recent study contributed new evidence that strengthens the hypothesis that the peptide humanin protects the brain against the development of Alzheimer's disease and other age-related dementias.

Humanin (HN) is a 24-amino acid mitochondria-associated peptide. More...
Since its initial discovery more than 10 years ago, a role for HN has been reported in many biological processes such as apoptosis, cell survival, substrate metabolism, inflammatory response, and response to stressors such as oxidative stress, ischemia, and starvation. Mounting evidence has suggested that HN and other mitochondrial derived peptides play a role in several age-related conditions including neurodegenerative disease.

In light of findings that HN levels decrease with age, investigators at the University of Southern California (Los Angeles, USA) sought to confirm that humanin played an important function in the aging process and the onset of age-related diseases.

To this end, they used a mitochondrial GWAS (genome-wide association study) to identify a specific single-nucleotide polymorphism (SNP) in the humanin-coding region of the mitochondrial genome that was associated with a 14% decrease in circulating humanin levels. In a large, independent cohort, consisting of a nationally representative sample of older adults, the investigators found that this SNP was associated with accelerated cognitive aging; supporting the concept that humanin is an important factor in cognitive aging.

The investigators further reported in the September 21, 2018, online edition of the journal Scientific Reports that mice injected with humanin experienced a delay in cognitive decline associated with aging.

"Because of the beneficial effects of humanin, a decrease in circulating levels could lead to an increase in several different diseases of aging, particularly in dementia," said senior author Dr. Pinchas Cohen, professor of gerontology, medicine, and biological sciences at the University of Southern California. "This provides the first evidence that a variation in the sequence of a mitochondrial peptide is associated with a change in the level of peptides and the first conclusive demonstration that mitochondrial peptides are encoded in and regulated through mitochondrial DNA."

Related Links:
University of Southern California


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Clinical Informatics Platform
CLARION™
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.